Physician profile
Ryan C Gustus
NPI 1285922716
$47,909.50
in general payments reported to CMS, 2019-2025
10 companies · $3,199 in 2025
The $3,199 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $49.20 · 2021: $166 · 2022: $245 · 2023: $3,928 · 2024: $40K · 2025: $3,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Consulting Fee: $1,400 · Entertainment: $281 · Travel and Lodging: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43,841.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Consulting Fee | $1,400.00 |
| Entertainment | $281.05 |
| Travel and Lodging | $210.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $43,225.26 | 2024-2025 | M22, Optilight |
| Coopervision INC. | $2,297.37 | 2019-2025 | Cvi Contact Lens, Clariti Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $1,400.00 | 2023 | Zenlens |
| Optos, INC. | $390.74 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $291.36 | 2019-2025 | Precision 1, Precision7 |
| Allergan, INC. | $187.15 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $52.11 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $40.49 | 2019-2024 | |
| Oyster Point Pharma, INC. | $12.76 | 2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gustus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.